According to Inozyme Pharma's latest financial reports the company's current EPS (TTM) is -ยฃ1.20. In 2022 the company made an earnings per share (EPS) of -ยฃ1.47 a decrease over its 2021 EPS that were of -ยฃ1.37.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -ยฃ1.29 | -12.14% |
2022 | -ยฃ1.47 | 6.78% |
2021 | -ยฃ1.37 | -41.04% |
2020 | -ยฃ2.33 | 130.75% |
2019 | -ยฃ1.01 |